Mednax Inc (MD)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -99,069 -253,836 -233,004 -51,697 -41,526 112,420 102,875 101,729 66,578 84,435 84,502 92,377 130,964 19,152 -52,687 -760,134 -796,488 -722,861 -1,937,737 -1,273,546
Revenue (ttm) US$ in thousands 2,012,919 2,006,998 2,002,452 1,998,733 1,994,640 2,012,041 1,995,344 1,980,800 1,972,021 1,956,707 1,959,741 1,946,667 1,911,191 1,829,291 1,796,977 1,833,221 2,232,386 2,721,131 3,149,171 3,508,277
Net profit margin -4.92% -12.65% -11.64% -2.59% -2.08% 5.59% 5.16% 5.14% 3.38% 4.32% 4.31% 4.75% 6.85% 1.05% -2.93% -41.46% -35.68% -26.56% -61.53% -36.30%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-99,069K ÷ $2,012,919K
= -4.92%

Net profit margin is a key financial ratio that indicates the percentage of revenue that translates into profit after all expenses have been deducted. For Mednax Inc, the net profit margin has shown a fluctuating trend over the past few quarters.

From March 31, 2020, to June 30, 2021, the company experienced negative net profit margins ranging from -36.30% to -2.93%, indicating that Mednax was not generating sufficient profits relative to its revenue during this period. However, there was a notable improvement in profitability from September 30, 2021, onwards, with the net profit margin turning positive and gradually increasing to 5.59% by September 30, 2023. This upward trend suggests that the company was able to control costs and improve operational efficiency, resulting in a more favorable profit margin.

Despite the positive trend observed in the latter part of the analysis period, the net profit margin dipped back into negative territory by the end of December 31, 2024, at -4.92%. This decrease may indicate challenges faced by Mednax in managing expenses or generating sufficient profits relative to its revenue.

In conclusion, the analysis of Mednax Inc's net profit margin reveals both positive and challenging aspects of the company's profitability performance. It is essential for the company to focus on maintaining a sustainable level of profitability to ensure long-term financial health and growth.


Peer comparison

Dec 31, 2024

Company name
Symbol
Net profit margin
Mednax Inc
MD
-4.92%
Encompass Health Corp
EHC
8.48%
Select Medical Holdings
SEM
4.13%